학술논문
Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Meta-analysis
Document Type
Article
Author
Albert, Christian; Zapf, Antonia; Haase, Michael; Röver, Christian; Pickering, John W.; Albert, Annemarie; Bellomo, Rinaldo; Breidthardt, Tobias; Camou, Fabrice; Chen, Zhongquing; Chocron, Sidney; Cruz, Dinna; de Geus, Hilde R.H.; Devarajan, Prasad; Di Somma, Salvatore; Doi, Kent; Endre, Zoltan H.; Garcia-Alvarez, Mercedes; Hjortrup, Peter B.; Hur, Mina; Karaolanis, Georgios; Kavalci, Cemil; Kim, Hanah; Lentini, Paolo; Liebetrau, Christoph; Lipcsey, Miklós; Mårtensson, Johan; Müller, Christian; Nanas, Serafim; Nickolas, Thomas L.; Pipili, Chrysoula; Ronco, Claudio; Rosa-Diez, Guillermo J.; Ralib, Azrina; Soto, Karina; Braun-Dullaeus, Rüdiger C.; Heinz, Judith; Haase-Fielitz, Anja
Source
American Journal of Kidney Diseases; December 2020, Vol. 76 Issue: 6 p826-841.e1
Subject
Language
ISSN
02726386; 15236838
Abstract
The usefulness of measures of neutrophil gelatinase-associated lipocalin (NGAL) in urine or plasma obtained on clinical laboratory platforms for predicting acute kidney injury (AKI) and AKI requiring dialysis (AKI-D) has not been fully evaluated. We sought to quantitatively summarize published data to evaluate the value of urinary and plasma NGAL for kidney risk prediction.